Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Go back to Glaukos Submits New Drug Application to U.S. FDA for Epioxa™| (NYSE: GKOS) | Delayed: 161.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.59 | 52 Week High | $39.82 | |||
| Open | $161.59 | 52 Week Low | $14.25 | |||
| Day High | $161.59 | P/E | N/A | |||
| Day Low | $161.59 | EPS | $0.00 | |||
| Volume | 74 | |||||



